OTC

Why Excedrin embraced the headache of a contentious election season

Why Excedrin embraced the headache of a contentious election season

By

Excedrin's #DebateHeadache was inspired by complaints the brand noticed during the first presidential debate in September.

Is This the End of Agency Diversification?

Is This the End of Agency Diversification?

By

DTC and OTC/wellness can borrow from mainstream consumer shops. Professional marketing may pose a tougher sell.

Langland's Andrew Spurgeon on Simplicity in Ads

Langland's Andrew Spurgeon on Simplicity in Ads

Spurgeon on finding simplicity in Procter & Gamble's "The Boy Raised by Goats" and a moving campaign about disabilities.

Five things for pharma marketers to know: Thursday, December 31, 2015

Five things for pharma marketers to know: Thursday, December 31, 2015

By

Generic Nexium will be blue; researcher says scientific papers should be anonymous; patients with health insurance still struggle to cover the costs of drugs

Pfizer ends bid for OTC Lipitor

Pfizer ends bid for OTC Lipitor

By

The drugmaker told investors that the actual-use trial failed to meet the primary objectives.

OPINION

Email Newsletters